Codexis (CDXS) Research & Development (2010 - 2026)
Codexis' (CDXS) quarterly Research & Development came in at $11.4 million in Q1 2026, down 11.54% year-on-year from $12.9 million in Q1 2025, and down 2.33% quarter-over-quarter from $11.7 million in Q4 2025.
Codexis (CDXS) Research & Development (2010 - 2026) Analysis & Trends
Codexis' Research & Development history runs 17 years deep, the most recent figure standing at $11.4 million for Q1 2026.
- On a quarterly basis, Research & Development fell 11.54% year-over-year to $11.4 million in Q1 2026; TTM through Mar 2026 was $50.8 million, a 5.95% increase from a year earlier, with the FY2025 full-year figure at $52.3 million, up 13.06% from the prior year.
- Research & Development declined to $11.4 million in Q1 2026 per CDXS's latest filing, from $11.7 million in the prior quarter.
- Across five years, Research & Development topped out at $21.8 million in Q3 2022 and bottomed at $11.2 million in Q4 2023.
- The 5-year median for Research & Development is $13.7 million (2023), against an average of $14.6 million.
- Across the five-year window, Research & Development surged 68.52% in 2022 and sank 42.94% in 2023, its largest moves.
- Year by year, Research & Development stood at $19.7 million in 2022, then slumped by 42.94% to $11.2 million in 2023, then climbed by 7.7% to $12.1 million in 2024, then dropped by 3.12% to $11.7 million in 2025, then retreated by 2.33% to $11.4 million in 2026.
- Per Business Quant, the three latest CDXS Research & Development figures stand at $11.4 million (Q1 2026), $11.7 million (Q4 2025), and $13.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | 11.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.45 Mn |
| Dec 31, 2025 | 11.72 Mn |
| Sep 30, 2025 | 13.87 Mn |
| Jun 30, 2025 | 13.78 Mn |
| Mar 31, 2025 | 12.94 Mn |
| Dec 31, 2024 | 12.10 Mn |
| Sep 30, 2024 | 11.51 Mn |
| Jun 30, 2024 | 11.41 Mn |
| Mar 31, 2024 | 11.25 Mn |
| Dec 31, 2023 | 11.23 Mn |
| Sep 30, 2023 | 13.66 Mn |
| Jun 30, 2023 | 17.33 Mn |
| Mar 31, 2023 | 16.66 Mn |
| Dec 31, 2022 | 19.69 Mn |
| Sep 30, 2022 | 21.82 Mn |
| Jun 30, 2022 | 19.09 Mn |
| Mar 31, 2022 | 19.50 Mn |
| Dec 31, 2021 | 16.36 Mn |
| Sep 30, 2021 | 15.17 Mn |
| Jun 30, 2021 | 12.83 Mn |